- Home
- CRBU
as 11-08-2024 2:33pm EST
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | BERKELEY |
| Market Cap: | 236.3M | IPO Year: | 2021 |
| Target Price: | $14.00 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.50 - $8.33 | Next Earning Date: | 11-06-2024 |
| Revenue: | $11,475,000 | Revenue Growth: | -66.85% |
| Revenue Growth (this year): | -63.27% | Revenue Growth (next year): | 3.24% |
Latest Caribou Biosciences Inc. News
CRBU Breaking Stock News: Dive into CRBU Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 hours ago
Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Zacks
2 days ago
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates
GlobeNewswire
2 days ago
Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Insider Monkey
9 days ago
Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock?
GuruFocus.com
22 days ago
STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc
GlobeNewswire
a month ago
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
Simply Wall St.
2 months ago
With 60% ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) boasts of strong institutional backing
MT Newswires
2 months ago
Caribou Biosciences CFO Jason O'Byrne Resigns
Compare CRBU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRBU Caribou Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.